Serial FDG-PET on patients with head and neck cancer: Implications for radiation therapy
- 1 January 2009
- journal article
- clinical trial
- Published by Taylor & Francis in International Journal of Radiation Biology
- Vol. 85 (9) , 796-804
Abstract
Purpose: To assess possible consequences for radiotherapy (RT) planning, e.g., reduction of treatment volume by a decreased tumour volume in Fluor-18-fluoro-deoxy-glucose-Positron emission tomography (FDG-PET) based on a close-meshed evaluation of FDG uptake in primary head and neck cancer (HNC) during RT. Materials and method: PET data were analysed using a source-to-background based algorithm. The following parameters were obtained: max. standardised uptake value (SUVmax), PET-based gross tumour volume (GTV-PET) and metabolic volume (MV). Results: While the median SUVmax decreased (initial: 15.2, 1st/2nd week: 10.2, 3rd/4th week: 6.5, 5th/6th week: 6.4), the median values of GTV-PET (9.3 cm3, 12.4 cm3, 14.0 cm3, 17.9 cm3) and MV (92.2 cm3, 61.7 cm3, 60.0 cm3, 71.3 cm3) seemed to increase during radiotherapy. The intra-individual development of SUVmax could be divided into two groups: group A having continuously decreasing values of SUVmax (n = 10 patients), and group B having a temporary increase of SUVmax (n = 13). Conclusions: Data suggest that a reduction of treatment volume is not possible by an adaptive re-planning based on FDG-PET, e.g., at 50 Gy. This may be caused by a consecutive therapy associated inflammation. This limitation is probably related to the use of a source-to-background based algorithm.Keywords
This publication has 24 references indexed in Scilit:
- Evidence-based radiation oncology in head and neck squamous cell carcinomaRadiotherapy and Oncology, 2007
- A gradient-based method for segmenting FDG-PET images: methodology and validationEuropean Journal of Nuclear Medicine and Molecular Imaging, 2007
- Posttreatment assessment of response using FDG-PET/CT for patients treated with definitive radiation therapy for head and neck cancersInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006
- Technology Insight: PET and PET/CT in head and neck tumor staging and radiation therapy planningNature Clinical Practice Oncology, 2005
- Combined PET-CT in the Head and NeckRadioGraphics, 2005
- Combined PET-CT in the Head and NeckRadioGraphics, 2005
- Dual Modality of 18F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in Patients with Cervical Carcinoma of Unknown PrimaryMedical Principles and Practice, 2005
- Hyperfractionated Accelerated Chemoradiation With Concurrent Fluorouracil-Mitomycin Is More Effective Than Dose-Escalated Hyperfractionated Accelerated Radiation Therapy Alone in Locally Advanced Head and Neck Cancer: Final Results of the Radiotherapy Cooperative Clinical Trials Group of the German Cancer Society 95-06 Prospective Randomized TrialJournal of Clinical Oncology, 2005
- Tumor Volume in Pharyngolaryngeal Squamous Cell Carcinoma: Comparison at CT, MR Imaging, and FDG PET and Validation with Surgical SpecimenRadiology, 2004
- Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: A systematic review of the published literature with subgroup analysisHead & Neck, 2001